The deadline to request to speak during the meeting has passed. If you have already submitted a request, FDA will determine the amount of time allotted to each commenter, decide the approximate time each comment is to begin, and select and notify participants by September 10, 2026. You may still comments to the docket until October 17, 2026 at: https://www.federalregister.gov/documents/2026/08/11/2026-16353/reauthorization-of-the-generic-drug-user-fee-amendments-public-meeting-request-for-comments